Inoue Y | Osaka Univ. Osaka Jpn
スポンサーリンク
概要
関連著者
-
Isobe Y
Research Division Discovery Research Laboratories Ii Sumitomo Pharmaceuticals Co. Ltd.
-
Fukaya C
Yoshitomi Pharmaceutical Ind. Ltd. Osaka Jpn
-
Fukaya Chikara
Quality Control Production Division Yoshitomi Pharmaceutical Industries Ltd.
-
Yoshida Tomohiro
Exploratory Research Ii Drug Discovery Laboratories Yoshitomi Pharmaceutical Industries Ltd.
-
Nakamura Norifumi
President's Office Yoshitomi Pharmaceutical Industries Ltd.
-
Nakamura Norihiro
Department Of Biological Sciences Graduate School Of Science Osaka University
-
五十部 穣
Research Center Sumitomo Pharmaceuticals Co. Ltd.
-
Inoue Y
Department Of Pharmacokinetics Kyoto Pharmaceutical University
-
KOSAKA Keigo
Enabling Technologies, Drug Discovery Laboratories, Yoshitomi Pharmaceutical Industries, Ltd.,
-
INOUE Yoshihisa
Enabling Technologies, Drug Discovery Laboratories, Yoshitomi Pharmaceutical Industries, Ltd.,
-
IMADA Teruaki
Exploratory Research II Drug Discovery Laboratories, Yoshitomi Pharmaceutical Industries, Ltd.,
-
Kosaka K
Beauty Care Products Division Health Care Business Group Nagase & Co. Ltd.
-
Imada T
Mitsubishi Pharma Corp. Yokohama Jpn
-
Inoue Y
Osaka Univ. Osaka Jpn
-
Yoshida T
Hakodate Institute Of National College Of Technology
-
Ono Shin'ichiro
Exploratory Research Ii Drug Discovery Laboratories Yoshitomi Pharmaceutical Industries Ltd.
-
MAEDA Kazuhiro
Exploratory Research II Drug Discovery Laboratories, Yoshitomi Pharmaceutical Industries, Ltd.,
-
ASHIMORI Atsuyuki
Exploratory Research II Drug Discovery Laboratories, Yoshitomi Pharmaceutical Industries, Ltd.,
-
Ashimori A
Exploratory Research Ii Drug Discovery Laboratories Yoshitomi Pharmaceutical Industries Ltd.
-
Maeda Kazuhiro
Exploratory Research Ii Drug Discovery Laboratories Yoshitomi Pharmaceutical Industries Ltd.
著作論文
- Preparation and Pharmacological Evaluation of Novel Glycoprotein (Gp) IIb/IIIa Antagonists. 2. Condensed Heterocyclic Derivatives
- Preparation and Pharmacological Evaluation of Novel Glycoprotein (Gp) IIb/IIIa Antagonists. 1. The Selection of Naphthalene Derivatives